Showing results (431-440 of 676) with videos related to
Sort By:
Pageof 68
Clinical Advances in Hematology & Oncology : H&O|September 9, 2020
Clinical Significance and Management of MRD in Adults With Acute Lymphoblastic LeukemiaHugo Akabane, Aaron LoganClinical Advances in Hematology & Oncology : H&O|December 14, 2018
Evolving landscape of the treatment of metastatic clear cell renal cell carcinomaPooja Ghatalia, Matthew R Zibelman, Daniel M Geynisman, et al.Clinical Advances in Hematology & Oncology : H&O|May 17, 2022
Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancerMatthew B Rettig, Himisha Beltran, William K OhClinical Advances in Hematology & Oncology : H&O|May 17, 2022
Systemic management of brain metastases in HER2+ breast cancer in 2022Laura Alder, Sarah Sammons, Amanda E D Van Swearingen, et al.Clinical Advances in Hematology & Oncology : H&O|July 8, 2021
Emerging role for local therapy in oligometastatic prostate cancerNabila R Khondakar, Jeunice Owens-Walton, Michael Daneshvar, et al.Clinical Advances in Hematology & Oncology : H&O|January 6, 2021
Current antibody-based therapies for the treatment of multiple myelomaCindy Varga, Johannes M Waldschmidt, Sara Gandolfi, et al.Clinical Advances in Hematology & Oncology : H&O|November 4, 2022
Ongoing progress in BRAF-mutated non-small cell lung cancerPamela Abdayem, David PlanchardClinical Advances in Hematology & Oncology : H&O|September 20, 2022
A narrative review of anti-SARS-CoV-2 vaccines and immune thrombocytopenia: be aware, but reassuredMarina Beltrami-Moreira, James B BusselClinical Advances in Hematology & Oncology : H&O|April 11, 2019
Treatment of relapsed/refractory acute lymphoblastic leukemiaShilpa Paul, Caitlin R Rausch, Patrice E Nasnas, et al.Clinical Advances in Hematology & Oncology : H&O|March 15, 2022
Optimizing administration of third-line treatment in metastatic colorectal cancerGerald W Prager, Michel Ducreux, Guillem ArgilésPageof 68